Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1953 1
1968 2
1972 1
1974 2
1975 2
1976 1
1977 2
1978 1
1979 1
1980 1
1981 4
1982 1
1983 3
1984 2
1986 2
1987 1
1989 1
1990 2
1991 3
1992 3
1993 3
1994 4
1995 5
1996 4
1997 5
1998 3
1999 2
2000 5
2001 2
2003 1
2004 2
2005 2
2006 3
2008 2
2009 13
2010 7
2011 7
2012 6
2013 6
2014 3
2015 4
2016 1
2017 4
2018 5
2019 1
2020 4
2021 3
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, Xiao J, Hooper AT, Hamilton JD, Musser BJ, Rofail D, Hussein M, Im J, Atmodjo DY, Perry C, Pan C, Mahmood A, Hosain R, Davis JD, Turner KC, Baum A, Kyratsous CA, Kim Y, Cook A, Kampman W, Roque-Guerrero L, Acloque G, Aazami H, Cannon K, Simón-Campos JA, Bocchini JA, Kowal B, DiCioccio AT, Soo Y, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD; Trial Investigators. Weinreich DM, et al. N Engl J Med. 2021 Dec 2;385(23):e81. doi: 10.1056/NEJMoa2108163. Epub 2021 Sep 29. N Engl J Med. 2021. PMID: 34587383 Free PMC article. Clinical Trial.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
O'Brien MP, Forleo-Neto E, Sarkar N, Isa F, Hou P, Chan KC, Musser BJ, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Brown ER, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; COVID-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. JAMA. 2022 Feb 1;327(5):432-441. doi: 10.1001/jama.2021.24939. JAMA. 2022. PMID: 35029629 Free PMC article. Clinical Trial.
Neural Versus Gonadal GnIH: Are they Independent Systems? A Mini-Review.
Bentley GE, Wilsterman K, Ernst DK, Lynn SE, Dickens MJ, Calisi RM, Kriegsfeld LJ, Kaufer D, Geraghty AC, viviD D, McGuire NL, Lopes PC, Tsutsui K. Bentley GE, et al. Among authors: dickens mj. Integr Comp Biol. 2017 Dec 1;57(6):1194-1203. doi: 10.1093/icb/icx085. Integr Comp Biol. 2017. PMID: 28992195 Review.
Insulin-activated protein kinases in fat and other cells.
Denton RM, Tavaré JM, Borthwick A, Dickens M, Diggle TA, Edgell NJ, Heesom KJ, Isaad T, Lynch DF, Moule SK, et al. Denton RM, et al. Among authors: dickens m. Biochem Soc Trans. 1992 Aug;20(3):659-64. doi: 10.1042/bst0200659. Biochem Soc Trans. 1992. PMID: 1426609 Review. No abstract available.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
O'Brien MP, Forleo-Neto E, Musser BJ, Isa F, Chan KC, Sarkar N, Bar KJ, Barnabas RV, Barouch DH, Cohen MS, Hurt CB, Burwen DR, Marovich MA, Hou P, Heirman I, Davis JD, Turner KC, Ramesh D, Mahmood A, Hooper AT, Hamilton JD, Kim Y, Purcell LA, Baum A, Kyratsous CA, Krainson J, Perez-Perez R, Mohseni R, Kowal B, DiCioccio AT, Stahl N, Lipsich L, Braunstein N, Herman G, Yancopoulos GD, Weinreich DM; Covid-19 Phase 3 Prevention Trial Team. O'Brien MP, et al. N Engl J Med. 2021 Sep 23;385(13):1184-1195. doi: 10.1056/NEJMoa2109682. Epub 2021 Aug 4. N Engl J Med. 2021. PMID: 34347950 Free PMC article. Clinical Trial.
Changes to insulin sensitivity in glucose clearance systems and redox following dietary supplementation with a novel cysteine-rich protein: A pilot randomized controlled trial in humans with type-2 diabetes.
Peeters WM, Gram M, Dias GJ, Vissers MCM, Hampton MB, Dickerhof N, Bekhit AE, Black MJ, Oxbøll J, Bayer S, Dickens M, Vitzel K, Sheard PW, Danielson KM, Hodges LD, Brønd JC, Bond J, Perry BG, Stoner L, Cornwall J, Rowlands DS. Peeters WM, et al. Among authors: dickens m. Redox Biol. 2023 Nov;67:102918. doi: 10.1016/j.redox.2023.102918. Epub 2023 Oct 5. Redox Biol. 2023. PMID: 37812879 Free PMC article. Clinical Trial.
139 results